Company · CIK 0001022079 · SIC 8071 — Services-Medical Laboratories · NYSE
QUEST DIAGNOSTICS INC · DGX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2018 SForm 4 → | Mar 1, 5:08 pm EST | Michael E PrevoznikSVP & General Counsel | 1,423 | $104.41 | $148,576 | 39,766 | −3.45% | plan? |
| Feb 27, 2018 FForm 4 → | Mar 1, 5:08 pm EST | Michael E PrevoznikSVP & General Counsel | 482 | $101.43 | $48,889 | 41,189 | — | plan? |
| Feb 27, 2018 FForm 4 → | Mar 1, 5:05 pm EST | Robert A KlugVP, Corporate Controller | 62 | $101.43 | $6,289 | 3,841 | — | plan? |
| Feb 27, 2018 FForm 4 → | Mar 1, 5:03 pm EST | Mark GuinanExecutive Vice President & CFO | 585 | $101.43 | $59,337 | 52,090 | — | plan? amended |
| Feb 27, 2018 SForm 4 → | Mar 1, 4:58 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 1,820 | $104.38 | $189,971 | 67,941 | −2.61% | plan? |
| Feb 27, 2018 FForm 4 → | Mar 1, 4:58 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 556 | $101.43 | $56,395 | 69,761 | — | plan? |
| Feb 27, 2018 SForm 4 → | Mar 1, 4:56 pm EST | J. E. DavisEVP, General Diagnostics | 1,798 | $104.42 | $187,749 | 37,023 | −4.63% | plan? |
| Feb 27, 2018 FForm 4 → | Mar 1, 4:56 pm EST | J. E. DavisEVP, General Diagnostics | 856 | $101.43 | $86,824 | 38,821 | — | plan? |
| Feb 27, 2018 FForm 4 → | Mar 1, 4:36 pm EST | Everett CunninghamSVP, Commercial | 556 | $101.43 | $56,395 | 40,317 | — | plan? |
| Feb 27, 2018 FForm 4 → | Mar 1, 4:32 pm EST | Jon R CohenSVP & Group Exec. Diag. Sol. | 556 | $101.43 | $56,395 | 70,942 | — | plan? |
| Feb 26, 2018 SForm 4 → | Feb 27, 4:40 pm EST | Robert A KlugVP, Corporate Controller | 1,157 | $103.66 | $119,932 | 3,903 | −22.9% | plan? |
| Feb 26, 2018 SForm 4 → | Feb 27, 4:38 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 397 | $102.74 | $40,788 | 70,317 | −0.56% | plan? |
| Feb 26, 2018 SForm 4 → | Feb 27, 4:37 pm EST | J. E. DavisEVP, General Diagnostics | 494 | $102.74 | $50,754 | 39,677 | −1.23% | plan? |
| Feb 23, 2018 FForm 4/A → | Mar 6, 7:45 pm EST | Mark GuinanExecutive Vice President & CFO | 2,046 | $101.79 | $208,272 | 52,313 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 4:53 pm EST | Michael E PrevoznikSVP & General Counsel | 1,217 | $101.76 | $123,840 | 41,671 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 4:41 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 7,357 | $101.79 | $748,859 | 173,725 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 4:40 pm EST | Robert A KlugVP, Corporate Controller | 120 | $101.88 | $12,226 | 5,060 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 4:39 pm EST | Mark GuinanExecutive Vice President & CFO | 1,684 | $101.87 | $171,554 | 52,675 | — | plan? amended |
| Feb 23, 2018 FForm 4 → | Feb 27, 4:38 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 1,598 | $101.73 | $162,572 | 70,714 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 4:37 pm EST | J. E. DavisEVP, General Diagnostics | 2,174 | $101.81 | $221,333 | 40,171 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 4:35 pm EST | Jon R CohenSVP & Group Exec. Diag. Sol. | 1,599 | $101.73 | $162,674 | 71,498 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 4:35 pm EST | Everett CunninghamSVP, Commercial | 1,599 | $101.73 | $162,674 | 40,873 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 4:32 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 387 | $102.69 | $39,741 | 21,274 | — | plan? |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:39 pm EST | Mark GuinanExecutive Vice President & CFO | 4,442 | — | — | 54,359 | — | plan? |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:37 pm EST | Robert A KlugVP, Corporate Controller | 541 | — | — | 5,180 | — | plan? |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:34 pm EST | J. E. DavisEVP, General Diagnostics | 4,249 | — | — | 42,345 | — | plan? |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:32 pm EST | Everett CunninghamSVP, Commercial | 2,897 | — | — | 42,472 | — | plan? |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:31 pm EST | Jon R CohenSVP & Group Exec. Diag. Sol. | 2,414 | — | — | 73,097 | — | plan? |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:30 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 14,966 | — | — | 181,082 | — | plan? |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:26 pm EST | Michael E PrevoznikSVP & General Counsel | 2,511 | — | — | 42,888 | — | plan? |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:23 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 2,897 | — | — | 72,312 | — | plan? |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:19 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 3,380 | — | — | 21,661 | — | plan? |
| Jan 29, 2018 SForm 4 → | Jan 31, 4:33 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 106,840 | $107.00 | $11,431,880 | 166,116 | −39.1% | plan? |
| Jan 29, 2018 MForm 4 → | Jan 31, 4:33 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 106,840 | $58.18 | $6,215,417 | 272,956 | — | plan? |
| Jan 24, 2018 SForm 4 → | Jan 26, 4:43 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 21,294 | $104.00 | $2,214,576 | 69,415 | −23.5% | plan? |
| Jan 24, 2018 MForm 4 → | Jan 26, 4:43 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 21,294 | $52.17 | $1,110,802 | 90,709 | — | plan? |
| Jan 2, 2018 SForm 4 → | Jan 4, 4:34 pm EST | J. E. DavisEVP, General Diagnostics | 63,880 | $98.68 | $6,303,359 | 38,053 | −62.7% | plan? |
| Jan 2, 2018 MForm 4 → | Jan 4, 4:34 pm EST | J. E. DavisEVP, General Diagnostics | 63,880 | $52.17 | $3,332,300 | 101,423 | — | plan? |
| Jan 2, 2018 FForm 4 → | Jan 4, 4:33 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 2,256 | $99.12 | $223,615 | 18,281 | — | plan? |
| Oct 13, 2017 FForm 4 → | Oct 17, 4:36 pm EDT | Robert A KlugVP, Corporate Controller | 9 | $91.10 | $820 | 4,515 | — | plan? |
| Sep 11, 2017 SForm 4 → | Sep 13, 6:20 pm EDT | Daniel StanzioneDirector | 40,900 | $108.07 | $4,419,940 | 34,675 | −54.1% | plan? |
| Sep 11, 2017 MForm 4 → | Sep 13, 6:20 pm EDT | Daniel StanzioneDirector | 40,900 | $57.15 | $2,337,327 | 75,575 | — | plan? |
| Sep 11, 2017 SForm 4 → | Sep 13, 6:18 pm EDT | Stephen H RusckowskiChairman, President and CEO, Director | 59,235 | $108.16 | $6,406,845 | 166,116 | −26.3% | plan? |
| Sep 11, 2017 MForm 4 → | Sep 13, 6:18 pm EDT | Stephen H RusckowskiChairman, President and CEO, Director | 59,235 | $58.18 | $3,445,996 | 171,418 | — | plan? |
| Sep 5, 2017 SForm 4 → | Sep 7, 4:43 pm EDT | Daniel StanzioneDirector | 3,803 | $108.01 | $410,762 | 34,675 | −9.88% | plan? |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:43 pm EDT | Daniel StanzioneDirector | 3,803 | $57.14 | $217,305 | 38,478 | — | plan? |
| Sep 5, 2017 SForm 4 → | Sep 7, 4:40 pm EDT | Stephen H RusckowskiChairman, President and CEO, Director | 2,525 | $108.03 | $272,768 | 166,116 | −1.50% | plan? |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:40 pm EDT | Stephen H RusckowskiChairman, President and CEO, Director | 2,525 | $58.18 | $146,892 | 168,413 | — | plan? |
| Aug 4, 2017 SForm 4 → | Aug 8, 4:27 pm EDT | Jeffrey M LeidenDirector | 296 | $106.66 | $31,571 | 6,000 | −4.70% | plan? |
| Aug 1, 2017 GForm 4 → | Aug 3, 4:30 pm EDT | Jon R CohenSVP & Group Exec. Diag. Sol. | 2,500 | — | — | 70,683 | — | plan? |
| Jul 27, 2017 SForm 4 → | Jul 31, 4:42 pm EDT | Jeffrey M LeidenDirector | 1,304 | $108.73 | $141,783 | 6,296 | −17.2% | plan? |
| Jun 19, 2017 SForm 4 → | Jun 21, 4:28 pm EDT | Jon R CohenSVP & Group Exec. Diag. Sol. | 106,900 | $107.55 | $11,497,134 | 73,183 | −59.4% | plan? |
| Jun 19, 2017 MForm 4 → | Jun 21, 4:28 pm EDT | Jon R CohenSVP & Group Exec. Diag. Sol. | 106,900 | $53.95 | $5,766,897 | 180,083 | — | plan? |
| Jun 19, 2017 SForm 4 → | Jun 21, 4:27 pm EDT | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 59,762 | $107.55 | $6,427,118 | 69,415 | −46.3% | plan? |
| Jun 19, 2017 MForm 4 → | Jun 21, 4:27 pm EDT | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 59,762 | $57.40 | $3,430,459 | 129,177 | — | plan? |
| May 19, 2017 GForm 4 → | May 23, 4:41 pm EDT | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 4,740 | — | — | 69,415 | — | plan? |
| May 16, 2017 AForm 4 → | May 18, 4:46 pm EDT | Daniel StanzioneDirector | 1,573 | — | — | 34,675 | — | plan? |
| May 16, 2017 AForm 4 → | May 18, 4:45 pm EDT | Timothy M RingDirector | 1,573 | — | — | 14,585 | — | plan? |
| May 16, 2017 AForm 4 → | May 18, 4:44 pm EDT | Gary M PfeifferDirector | 1,573 | — | — | 15,534 | — | plan? |
| May 16, 2017 AForm 4 → | May 18, 4:44 pm EDT | Timothy L MainDirector | 1,573 | — | — | 14,691 | — | plan? |
| May 16, 2017 AForm 4 → | May 18, 4:43 pm EDT | Jeffrey M LeidenDirector | 1,573 | — | — | 7,600 | — | plan? |
| May 16, 2017 AForm 4 → | May 18, 4:42 pm EDT | Vicky B GreggDirector | 1,573 | — | — | 8,525 | — | plan? |
| May 16, 2017 AForm 4 → | May 18, 4:41 pm EDT | Jenne K BritellDirector | 1,573 | — | — | 21,476 | — | plan? |
| May 16, 2017 AForm 4 → | May 18, 4:40 pm EDT | Gail R WilenskyDirector | 1,573 | — | — | 24,960 | — | plan? |
| Apr 24, 2017 SForm 4 → | Apr 26, 4:34 pm EDT | Jenne K BritellDirector | 6,111 | $104.03 | $635,727 | 19,903 | −23.5% | plan? |
| Apr 24, 2017 MForm 4 → | Apr 26, 4:34 pm EDT | Jenne K BritellDirector | 6,111 | $57.67 | $352,421 | 25,996 | — | plan? |
| Apr 20, 2017 SForm 4 → | Apr 24, 4:18 pm EDT | Michael E PrevoznikSVP & General Counsel | 29,513 | $100.00 | $2,951,300 | 40,327 | −42.3% | plan? |
| Apr 20, 2017 MForm 4 → | Apr 24, 4:18 pm EDT | Michael E PrevoznikSVP & General Counsel | 29,513 | $56.78 | $1,675,743 | 68,822 | — | plan? |
| Mar 16, 2017 SForm 4 → | Mar 20, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 13,987 | $100.00 | $1,398,700 | 40,322 | −25.8% | plan? |
| Mar 16, 2017 MForm 4 → | Mar 20, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 13,987 | $55.65 | $778,377 | 54,309 | — | plan? |
| Mar 3, 2017 SForm 4 → | Mar 6, 4:40 pm EST | Michael E PrevoznikSVP & General Counsel | 4,478 | $98.29 | $440,143 | 40,322 | −10.00% | plan? |
| Mar 2, 2017 SForm 4 → | Mar 6, 4:39 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 7,162 | $98.28 | $703,908 | 74,155 | −8.81% | plan? |
| Mar 2, 2017 AFForm 4 → | Mar 6, 4:39 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 19,012 | $98.12 | $1,865,457 | 81,317 | — | plan? |
| Mar 2, 2017 AFForm 4 → | Mar 3, 5:15 pm EST | Michael E PrevoznikSVP & General Counsel | 14,126 | $98.12 | $1,386,043 | 44,800 | — | plan? |
| Mar 2, 2017 AFForm 4 → | Mar 3, 5:13 pm EST | Robert A KlugVP, Corporate Controller | 1,636 | $98.12 | $160,524 | 4,330 | — | plan? |
| Mar 2, 2017 AFForm 4 → | Mar 3, 5:10 pm EST | Mark GuinanExecutive Vice President & CFO | 21,729 | $98.12 | $2,132,049 | 49,917 | — | plan? |
| Mar 2, 2017 AFForm 4 → | Mar 3, 5:08 pm EST | J. E. DavisEVP, General Diagnostics | 19,941 | $98.12 | $1,956,611 | 37,543 | — | plan? |
| Mar 2, 2017 AFForm 4 → | Mar 3, 5:07 pm EST | Everett CunninghamSVP, Commercial | 19,012 | $98.12 | $1,865,457 | 39,052 | — | plan? |
| Mar 2, 2017 AFForm 4 → | Mar 3, 5:01 pm EST | Jon R CohenSVP & Group Exec. Diag. Sol. | 18,922 | $98.12 | $1,856,627 | 73,183 | — | plan? |
| Mar 2, 2017 AFForm 4 → | Mar 3, 5:00 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 74,825 | $98.12 | $7,341,829 | 165,888 | — | plan? |
| Mar 1, 2017 SForm 4 → | Mar 3, 5:15 pm EST | Michael E PrevoznikSVP & General Counsel | 470 | $97.77 | $45,952 | 40,317 | −1.15% | plan? |
| Feb 28, 2017 FForm 4 → | Mar 2, 4:50 pm EST | Robert A KlugVP, Corporate Controller | 69 | $96.42 | $6,653 | 3,505 | — | plan? |
| Feb 28, 2017 FForm 4 → | Mar 2, 4:49 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 585 | $96.42 | $56,406 | 75,289 | — | plan? |
| Feb 28, 2017 FForm 4 → | Mar 2, 4:47 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 3,163 | $96.42 | $304,976 | 144,748 | — | plan? |
| Feb 28, 2017 FForm 4 → | Mar 2, 4:47 pm EST | Mark GuinanExecutive Vice President & CFO | 625 | $96.42 | $60,263 | 43,028 | — | plan? |
| Feb 28, 2017 FForm 4 → | Mar 2, 4:46 pm EST | Everett CunninghamSVP, Commercial | 585 | $96.42 | $56,406 | 32,978 | — | plan? |
| Feb 28, 2017 FForm 4 → | Mar 2, 4:43 pm EST | Michael E PrevoznikSVP & General Counsel | 507 | $96.42 | $48,885 | 40,787 | — | plan? |
| Feb 28, 2017 FForm 4 → | Mar 2, 4:42 pm EST | J. E. DavisEVP, General Diagnostics | 675 | $96.42 | $65,084 | 32,398 | — | plan? |
| Feb 28, 2017 FForm 4 → | Mar 2, 4:41 pm EST | Jon R CohenSVP & Group Exec. Diag. Sol. | 420 | $96.42 | $40,496 | 67,065 | — | plan? |
| Feb 27, 2017 SForm 4 → | Feb 28, 4:49 pm EST | Michael E PrevoznikSVP & General Counsel | 440 | $97.39 | $42,852 | 41,294 | −1.05% | plan? |
| Feb 24, 2017 FForm 4 → | Feb 28, 4:50 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 2,759 | $95.68 | $263,981 | 147,911 | — | plan? |
| Feb 24, 2017 FForm 4 → | Feb 28, 4:49 pm EST | Michael E PrevoznikSVP & General Counsel | 474 | $95.68 | $45,352 | 41,734 | — | plan? |
| Feb 24, 2017 FForm 4 → | Feb 28, 4:48 pm EST | J. E. DavisEVP, General Diagnostics | 600 | $95.68 | $57,408 | 33,073 | — | plan? |
| Feb 24, 2017 FForm 4 → | Feb 28, 4:47 pm EST | Robert A KlugVP, Corporate Controller | 43 | $95.68 | $4,114 | 3,574 | — | plan? |
| Feb 24, 2017 FForm 4 → | Feb 28, 4:45 pm EST | Mark GuinanExecutive Vice President & CFO | 585 | $95.68 | $55,973 | 43,653 | — | plan? |
| Feb 24, 2017 FForm 4 → | Feb 28, 4:44 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 638 | $95.68 | $61,044 | 75,874 | — | plan? |
| Feb 24, 2017 FForm 4 → | Feb 28, 4:42 pm EST | Everett CunninghamSVP, Commercial | 638 | $95.68 | $61,044 | 33,563 | — | plan? |
| Feb 24, 2017 FForm 4 → | Feb 28, 4:41 pm EST | Jon R CohenSVP & Group Exec. Diag. Sol. | 459 | $95.68 | $43,917 | 67,485 | — | plan? |
| Feb 22, 2017 SForm 4 → | Feb 24, 4:32 pm EST | John B ZieglerDirector | 2,000 | $95.51 | $191,016 | 16,557 | −10.8% | plan? |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:17 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 15,659 | — | — | 150,670 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2015 AForm 4 → | Jan 5, 5:07 pm EST | Jeffrey M LeidenDirector | 1,502 | — | — | 1,502 | — | |
| Jan 1, 2014 AForm 4 → | Oct 5, 2015, 4:34 pm EDT | Timothy M RingDirector | 2,646 | $63.73 | $168,595 | 2,646 | — | late |